Kaken Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3207000005
JPY
3,910.00
45 (1.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
18,867.00
18,045.00
24,618.00
33,118.00
18,254.00
17,359.00
18,514.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
18,867.00
18,045.00
24,618.00
33,118.00
18,254.00
17,359.00
18,514.00
Raw Material Cost
8,995.00
8,705.00
9,528.00
9,067.00
8,202.00
8,680.00
8,375.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.00
9.00
7.00
7.00
5.00
4.00
5.00
Selling and Distribution Expenses
4,476.00
5,557.00
4,665.00
4,247.00
4,303.00
3,998.00
4,015.00
Other Expenses
537.20
815.90
457.70
296.80
299.30
403.70
275.90
Total Expenditure (Excl Depreciation)
18,853.00
22,430.00
18,777.00
16,289.00
15,503.00
16,719.00
15,154.00
Operating Profit (PBDIT) excl Other Income
14
-4385
5841
16829
2751
640
3360
Other Income
408.00
-180.00
421.00
-18.00
232.00
-38.00
206.00
Operating Profit (PBDIT)
1,058.00
-3,936.00
6,883.00
17,458.00
3,640.00
1,276.00
4,237.00
Interest
10.00
9.00
7.00
7.00
5.00
4.00
5.00
Exceptional Items
1.00
-2,010.00
531.00
59.00
-605.00
-19.00
0.00
Gross Profit (PBDT)
9,872.00
9,340.00
15,090.00
24,051.00
10,052.00
8,679.00
10,139.00
Depreciation
636.00
629.00
621.00
647.00
657.00
674.00
671.00
Profit Before Tax
409.00
-6,586.00
6,786.00
16,864.00
2,371.00
576.00
3,562.00
Tax
137.00
-1,356.00
1,897.00
4,332.00
617.00
-775.00
955.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
271.00
-5,230.00
4,889.00
12,532.00
1,754.00
1,350.00
2,607.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
271.00
-5,230.00
4,889.00
12,532.00
1,754.00
1,350.00
2,607.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
271.00
-5,230.00
4,889.00
12,532.00
1,754.00
1,350.00
2,607.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,47,447.00
1,52,634.00
1,55,259.00
1,54,405.00
1,42,520.00
1,43,755.00
1,40,137.00
Earnings per share (EPS)
7.12
-136.18
129.09
330.91
46.32
35.65
68.84
Diluted Earnings per share
7.12
-136.18
129.09
330.91
46.32
35.65
68.84
Operating Profit Margin (Excl OI)
0.07%
-24.3%
23.73%
50.82%
15.07%
3.69%
18.15%
Gross Profit Margin
5.54%
-33.01%
30.09%
52.87%
16.59%
7.2%
22.86%
PAT Margin
1.44%
-28.98%
19.86%
37.84%
9.61%
7.78%
14.08%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 3.36% vs 0.57% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -84.55% vs -30.12% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -80.93% vs -13.44% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 100.00% vs 25.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Kaken Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
18,867.00
8,569.00
10,298.00
120.18%
Other Operating Income
0.00
0.00
0.00
Total Operating income
18,867.00
8,569.00
10,298.00
120.18%
Raw Material Cost
8,995.00
2,395.00
6,600.00
275.57%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.00
79.00
-69.00
-87.34%
Selling and Distribution Expenses
4,476.00
3,470.00
1,006.00
28.99%
Other Expenses
537.20
326.90
210.30
64.33%
Total Expenditure (Excl Depreciation)
18,853.00
9,213.00
9,640.00
104.63%
Operating Profit (PBDIT) excl Other Income
14.00
-644.00
658.00
102.17%
Other Income
408.00
-27.00
435.00
1,611.11%
Operating Profit (PBDIT)
1,058.00
67.00
991.00
1,479.10%
Interest
10.00
79.00
-69.00
-87.34%
Exceptional Items
1.00
0.00
1.00
Gross Profit (PBDT)
9,872.00
6,174.00
3,698.00
59.90%
Depreciation
636.00
738.00
-102.00
-13.82%
Profit Before Tax
409.00
-751.00
1,160.00
154.46%
Tax
137.00
-180.00
317.00
176.11%
Provisions and contingencies
0
0
0.00
Profit After Tax
271.00
-546.00
817.00
149.63%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
271.00
-546.00
817.00
149.63%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-24.00
24.00
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
271.00
-570.00
841.00
147.54%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,47,447.00
46,264.00
1,01,183.00
218.71%
Earnings per share (EPS)
7.12
-4.48
11.60
258.93%
Diluted Earnings per share
7.12
-4.48
11.60
258.93%
Operating Profit Margin (Excl OI)
0.07%
-7.52%
0.00
7.59%
Gross Profit Margin
5.54%
-0.15%
0.00
5.69%
PAT Margin
1.44%
-6.37%
0.00
7.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,886.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.56% vs -26.70% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.36% vs 0.57% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 27.10 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 105.18% vs -206.97% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -84.55% vs -30.12% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 65.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 117.31% vs -158.12% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -80.93% vs -13.44% in Jun 2024

Quarterly - Interest
Interest 1.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 11.11% vs 28.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 100.00% vs 25.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.07%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024